Transce3nd’s Hims & Hers Health HIMS Stock Holding History

Transce3nd’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-125	Closed	-$6.23K	–	589
2025 Q2	$6.23K	Buy	+125	New	+$5.65K	﹤0.01%	690

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transce3nd's HIMS Position: Q3 2025 in Review

Transce3nd sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 125 shares — an estimated $6.23K sold.

Transce3nd first reported a position in HIMS in Q2 2025 and held it in 1 quarter. The position peaked at $6.23K in Q2 2025. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

Transce3nd reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 125 Hims & Hers Health shares in Q3 2025, an estimated $6.23K.
Transce3nd first reported a position in Hims & Hers Health in Q2 2025 and held it in 1 quarter.
Transce3nd's Hims & Hers Health position peaked at $6.23K in Q2 2025.
512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.